NBIX vs SYY · P/E 45, rev $1.77B vs P/E 22, rev $84.55B
Neurocrine Biosciences Inc (NBIX) versus Sysco Corporation (SYY) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Sysco Corporation (SYY) is a food distribution company listed on NYSE.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SYY revenue for 2026-06-27 was $84.55B. Net income was $1.76B. Revenue was up 3.9% from 2025-06-28 to 2026-06-27. SYY currently screens at market cap $37.78B and trailing P/E 21.9.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SYY currently screens at market cap $37.78B and trailing P/E 21.9.
Not investment advice. Open the NBIX and SYY stock pages for the full models.
Not investment advice.